1
Views
7
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Evidence That Glucocorticoid- and Cyclic AMP-Induced Apoptotic Pathways in Lymphocytes Share Distal Events

&
Pages 3600-3608 | Received 22 Jan 1992, Accepted 14 May 1992, Published online: 01 Apr 2023

REFERENCES

  • Baughman, G., M. T. Harrigan, N. F. Campbell, S. J. Nurrish, and S. Bourgeois. 1991. Genes newly identified as regulated by glucocorticoids in murine thymocytes. Mol. Endocrinol. 5:637–644.
  • Bettuzzi, S., L. Troiano, P. Davalli, F. Tropea, M. C. Ingletti, E. Grassilli, D. Monti, A. Corti, and C. Franceschi. 1991. In vivo accumulation of sulfated glycoprotein 2 mRNA in rat thymocytes upon dexamethasone-induced cell death. Biochem. Biophys. Res. Commun. 175:810–815.
  • Bourgeois, S., and J. C. Gasson. 1985. Genetic and epigenetic bases of glucocorticoid resistance in lymphoid cell lines. Biochem. Actions Horm. 12:311–351.
  • Bourgeois, S., and R. F. Newby. 1977. Diploid and haploid states of the glucocorticoid receptor gene of mouse lymphoid cell lines. Cell 11:423–430.
  • Briehl, M. M., F. A. Flomerfelt, D. R. Dowd, E. S. Dieken, and R. L. Miesfeld. Submitted for publication.
  • Briehl, M. M., and R. L. Miesfeld. 1991. Isolation and characterization of transcripts induced by androgen withdrawal and apoptotic cell death in the rat ventral prostate. Mol. Endocrinol. 5:1381–1388.
  • Chen, L., G. Nuñez, and R. L. Miesfeld. Unpublished data.
  • Chi, C.-W., and M. M. Ip. 1988. Combined therapy with 5-azacytidine and hydrocortisone in glucocorticoid-sensitive and -resistant mouse P1798 lymphosarcoma. JNCI 89:912–918.
  • Cleary, M. L., S. D. Smith, and J. Sklar. 1986. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/ immunoglobulin transcript resulting from the t(14;18) translocation. Cell 47:19–28.
  • Coffino, P., R. Baumal, R. Laskov, and M. D. Scharff. 1972. Cloning of mouse myeloma cells and detection of rare variants. J. Cell. Physiol. 79:441–452.
  • Daniel, V., G. Litwack, and G. M. Tomkins. 1973. Induction of cytolysis of cultured lymphoma cells by adenosine 3′:5′-cyclic monophosphate and the isolation of resistant variants. Proc. Natl. Acad. Sci. USA 70:76–79.
  • Danielsen, M., D. O. Peterson, and M. R. Stallcup. 1983. Immunological selection of variant mouse lymphoid cells with altered glucocorticoid responsiveness. Mol. Cell. Biol. 3:1310–1316.
  • Danielsen, M., and M. R. Stallcup. 1984. Down-regulation of glucocorticoid receptors in mouse lymphoma cell variants. Mol. Cell. Biol. 4:449–453.
  • Delegeane, A. M., L. H. Ferland, and P. L. Mellon. 1987. Tissue-specific enhancer of the human glycoprotein hormone α-subunit gene: dependence on cyclic AMP-inducible elements. Mol. Cell. Biol. 7:3994–4002.
  • DeVita, V. T., Jr., S. M. Hubbard, and D. L. Longo. 1987. The chemotherapy of lymphomas: looking back, moving forward—the Richard and Hinda Rosenthal Foundation Award lecture. Cancer Res. 47:5810–5824.
  • Dieken, E. S., and R. L. Miesfeld. 1992. Transcriptional transactivation functions localized to the glucocorticoid receptor N terminus are necessary for steroid induction of lymphocyte apoptosis. Mol. Cell. Biol. 12:589–597.
  • Dowd, D. R., P. N. MacDonald, B. S. Komm, M. R. Haussler, and R. L. Miesfeld. 1991. Evidence for early induction of calmodulin gene expression in lymphocytes undergoing glucocorticoid-mediated apoptosis. J. Biol. Chem. 266:18423–18426.
  • Dowd, D. R., and R. L. Miesfeld. Unpublished data.
  • Duvall, E., and A. H. Wyllie. 1986. Death and the cell. Immunol. Today 7:115–119.
  • Edelman, A. M., D. K. Blumenthal, and E. G. Krebs. 1987. Protein serine/threonine kinases. Annu. Rev. Biochem. 56:567–613.
  • Flomerfelt, F. A., and R. L. Miesfeld. Unpublished data.
  • Friedrich, U., and P. Coffino. 1977. Mutagenesis in S49 mouse lymphoma cells: induction of resistance to ouabain, 6-thioguanine, and dibutyryl cyclic AMP. Proc. Natl. Acad. Sci. USA 74:679–683.
  • Galili, U., A. Peleg, Y. Milner, and N. Galili. 1984. Be13, a human T-leukemia cell line highly sensitive to dexamethasone- induced cytolysis. Cancer Res. 44:4594–4601.
  • Gasson, J. C., and S. Bourgeois. 1983. A new determinant of glucocorticoid sensitivity in lymphoid cell lines. J. Cell Biol. 96:409–415.
  • Gehring, U., and P. Coffino. 1977. Independent mechanisms of cyclic AMP and glucocorticoid action. Nature (London) 268:167–169.
  • Gruol, D. J., N. F. Campbell, and S. Bourgeois. 1986. Cyclic AMP-dependent protein kinase promotes glucocorticoid receptor function. J. Biol. Chem. 261:4909–4914.
  • Gruol, D. J., and D. K. Dalton. 1984. Phenothiazines cause a shift in the cAMP dose-response: selection of resistant variants in a murine thymoma line. J. Cell. Physiol. 119:107–118.
  • Harbour, D. V., P. Chambon, and E. B. Thompson. 1990. Steroid mediated lysis of lymphoblasts requires the DNA binding region of the steroid hormone receptor. J. Steroid Biochem. 35:1–9.
  • Harmon, J. M., M. R. Norman, B. J. Fowlkes, and E. B. Thompson. 1979. Dexamethasone induces irreversible G1 arrest and death of a human lymphoid cell line. J. Cell. Physiol. 98:267–278.
  • Harris, A. W., A. D. Bankhurst, S. Mason, and N. L. Warner. 1973. Differentiated functions expressed by cultured mouse lymphoma cells. J. Immunol. 110:431–438.
  • Hockenbery, D., G. Nunez, C. Milliman, R. D. Schreiber, and S. J. Korsmeyer. 1990. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (London) 348:334–336.
  • Hockenbery, D. M., M. Zutter, W. Hickey, M. Nahm, and S. J. Korsmeyer. 1991. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. USA 88:6961–6965.
  • Horibata, K., and A. W. Harris. 1970. Mouse myelomas and lymphomas in culture. Exp. Cell Res. 60:61–77.
  • Huet-Minkowski, M., J. C. Gasson, and S. Bourgeois. 1981. Induction of glucocorticoid-resistant variants in a murine thymoma line by antitumor drugs. Cancer Res. 41:4540–4546.
  • Huet-Minkowski, M., J. C. Gasson, and S. Bourgeois. 1982. Glucocorticoid resistance in lymphoid cell lines, p. 80–94. In N. Bruchovsky and J. H. Goldie (ed.), Drug and hormone resistance in neoplasia, vol. I. CRC Press, Boca Raton, Fla.
  • Insel, P. A., H. R. Bourne, P. Coffino, and G. M. Tomkins. 1975. Cyclic AMP-dependent protein kinase: pivotal role in regulation of enzyme induction and growth. Science 190:896–898.
  • Krishan, A. 1975. Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell Biol. 66:188–193.
  • Lanotte, M., J. B. Riviere, S. Hermouet, G. Houge, O. K. Vintermyr, B. T. Gjertsen, and S. O. Døskeland. 1991. Programmed cell death (apoptosis) is induced rapidly and with positive cooperativity by activation of cyclic adenosine monophosphate-kinase I in a myeloid leukemia cell line. J. Cell. Physiol. 146:73–80.
  • Lemaire, I., and P. Coffino. 1977. Cyclic AMP-induced cytolysis in S49 cells: selection of an unresponsive “deathless” mutant. Cell 11:149–155.
  • Lemaire, I., and P. Coffino. 1977. Coexpression of mutant and wild type protein kinase in lymphoma cells resistant to dibutyryl cyclic AMP. J. Cell. Physiol. 92:437–446.
  • McConkey, D. J., P. Nicotera, P. Hartzell, G. Bellomo, A. H. Wyllie, and S. Orrenius. 1989. Glucocorticoids activate a suicide process in thymocytes through an elevation of cytosolic Ca2+ concentration. Arch. Biochem. Biophys. 269:365–370.
  • McConkey, D. J., S. Orrenius, and M. Jondal. 1990. Agents that elevate cAMP stimulate DNA fragmentation in thymocytes. J. Immunol. 145:1227–1230.
  • Nordeen, S. K., and D. A. Young. 1976. Glucocorticoid action on rat thymic lymphocytes. J. Biol. Chem. 251:7295–7303.
  • Norman, M. R., and E. B. Thompson. 1977. Characterization of a glucocorticoid-sensitive human lymphoid cell line. Cancer Res. 37:3785–3791.
  • Nunez, G., L. London, D. Hockenbery, M. Alexander, J. P. McKearn, and S. J. Korsmeyer. 1990. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J. Immunol. 144:3602–3610.
  • Owens, G. P., W. E. Hahn, and J. J. Cohen. 1991. Identification of mRNAs associated with programmed cell death in immature thymocytes. Mol. Cell. Biol. 11:4177–4188.
  • Pezzella, F., A. Tse, J. L. Cordell, K. A. F. Pulford, K. C. Gatter, and D. Y. Mason. 1990. Expression of the bcl-2 oncogene protein is not specific for the 14; 18 chromosomal translo cation. Am. J. Pathol. 137:225–232.
  • Picard, D., and K. R. Yamamoto. 1987. Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor. EMBO J. 6:3333–3340.
  • Roesler, W. J., G. R. Vandenbark, and R. W. Hanson. 1988. Cyclic AMP and the induction of eukaryotic gene transcription. J. Biol. Chem. 263:9063–9066.
  • Roskoski, R., Jr. 1983. Assays of protein kinase. Methods Enzymol. 99:3–6.
  • Rundlett, S., X.-P. Wu, and R. L. Miesfeld. 1990. Functional characterizations of the androgen receptor confirm that the molecular basis of androgen action is transcriptional regulation. Mol. Endocrinol. 4:708–714.
  • Sentman, C. L., J. R. Shutter, D. Hockenbery, O. Kanagawa, and S. J. Korsmeyer. 1991. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67:879–888.
  • Silver, B. J., J. A. Bokar, J. B. Virgin, E. A. Vallen, A. Milsted, and J. H. Nilson. 1987. Cyclic AMP regulation of the human glycoprotein hormone α-subunit gene is mediated by an 18-base- pair element. Proc. Natl. Acad. Sci. USA 84:2198–2202.
  • Strasser, A., A. W. Harris, and S. Cory. 1991. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67:889–899.
  • Tada, H., O. Shiho, K.-L. Kuroshima, M. Koyama, and K. Tsukamoto. 1986. An improved colorimetric assay for interleukin 2. J. Immunol. Methods 93:157–165.
  • Thompson, E. B., J. R. Smith, S. Bourgeois, and J. M. Harmon. 1985. Glucocorticoid receptors in human leukemias and related diseases. Klin. Wochenschr. 63:689–698.
  • Vanderbilt, J. N., R. L. Miesfeld, B. A. Maler, and K. R. Yamamoto. 1987. Interacellular receptor concentration limits glucocorticoid-dependent enhancer activity. Mol. Endocrinol. 1:68–74.
  • Vaux, D. L., S. Cory, and J. M. Adams. 1988. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalise pre-B cells. Nature (London) 335:440–442.
  • Vedeckis, W. V., and H. D. Bradshaw, Jr. 1983. DNA fragmentation in S49 lymphoma cells killed with glucocorticoids and other agents. Mol. Cell. Endocrinol. 30:215–227.
  • Vukmanovic, S., and R. Zamoyska. 1991. Anti-CD3-induced cell death in T cell hybridomas: mitochondrial failure and DNA fragmentation are distinct events. Eur. J. Immunol. 21:419–424.
  • Wells, D., and L. Kedes. 1985. Structure of a human histone cDNA: evidence that basally expressed histone genes have intervening sequences and encode polyadenylylated mRNAs. Proc. Natl. Acad. Sci. USA 82:2834–2838.
  • Wyllie, A. H., J. F. R. Kerr, and A. R. Currie. 1980. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68:251–307.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.